A REVIEW ON NEW ANTIHYPERTENSIVE AGENT: IRBESARTAN

被引：0

作者：

Paras, Virani ^{[1
,2
]}

Sojitra, Rajanit ^{[2
]}

Raj, Hasumati ^{[2
]}

Jain, Vineet ^{[2
]}

机构：

[1] Gujarat Technol Univ, Ahmadabad, Gujarat, India

[2] Shree Dhanvantary Pharm Colls, Qual Assurance Dept, Surat, India

来源：

INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2015年 / 2卷 / 01期

关键词：

Irbesartan; Hypertension; Anti hypertensive drug; Angiotensin ii receptor antagonist;

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Hypertension is currently measure disorder obtain in the world population. Irbesartan is classified as an angiotensin II receptor type 1 antagonist. Angiotensin II receptor type 1 antagonists are widely used in treatment of diseases like hypertension, heart failure, myocardial infarction and diabetic nephropathy. The clinical and pharmacological analysis of this drug givesidea about effectivity of this drug in hypertension condition. Irbesartan act on renin angiotensin system and decreases biding of angiotensin to the receptor so decreases the blood pressure and act as an antihypertensive agent. Irbesartan is tetrazole derivative which selectively inhibit or antagonise the angiotensin type II receptor. In this review gives detail about mechanism of action of irbesartan in hypertension.

引用

页码：510 / 513

页数：4